Medium Bio is developing new assays & AI models to design functional, therapeutic antibodies. Antibodies are one of the most successful, effective, and efficacious class of therapies that have ever been made. Yet, there are several challenges with developing antibodies that can target specific epitopes to achieve functional changes that are important for unmet therapeutic needs.
We are developing new wet-lab techniques, paired with our AI model to unlock these new antibody capabilities. We are a venture-backed rapidly growing early stage startup.
We are hiring for the following roles with the expected start date in June/July 2025:
For updates on these roles, email: [email protected]